In 2026, medication costs are changing fast. Learn how generics, coupons, and prior authorizations affect your out-of-pocket bills-and what you can do to save money on prescriptions under the new Medicare rules.
Evergreening lets pharmaceutical companies extend drug monopolies with minor changes, blocking cheaper generics and keeping prices high. Learn how it works and why it hurts patients.
Generic drugs save the U.S. over $330 billion a year, but brand manufacturers face massive revenue losses when patents expire. Learn how patent cliffs, pay-for-delay deals, and PBM pricing distortions shape the real cost of medicine.
Modified-release formulations require specialized bioequivalence testing to ensure generics work as well as brand-name drugs. Learn how regulators assess release profiles, dissolution, and partial AUCs-and why some generics still fail patients.
Generic drugs cost 80-85% less than brand-name drugs because they don't need to repeat expensive clinical trials. They contain the same active ingredients, meet the same safety standards, and work just as well-saving patients billions each year.
The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug maker to challenge a patent a temporary monopoly. This law shapes drug prices, delays competition, and impacts patient access to affordable medications.